• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Simvastatin

Simvastatin

Product ID S3449
Cas No. 79902-63-9
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $65.40 In stock
25 mg $120.20 In stock
50 mg $150.30 In stock
100 mg $210.30 In stock
500 mg $630.90 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Simvastatin is an inhibitor of HMG-CoA reductase that exhibits anti-hyperlipidemic, anticonvulsant/antiepileptic, anti-osteoporotic, neuroprotective, cognition enhancing, antithrombotic, and anticancer chemotherapeutic activities. Clinically, simvastatin decreases levels of LDL and total cholesterol and lowers cardiovascular morbidity and mortality rates. Simvastatin decreases insulin synthesis and secretion in vitro, potentially through increasing ATP-sensitive K+ currents and inhibiting L-type Ca2+ currents. In animal models of Parkinson’s disease, simvastatin upregulates expression of M1/4 muscarinic acetylcholine receptors (mAChRs), improving long-term memory. In other animal models, simvastatin increases bone mineral density, bone volume fraction, and bone microarchitecture. Additionally, simvastatin decreases platelet activation and inhibits thrombus formation in vitro and in vivo. This compound also increases expression of p27 and decreases expression of histone methyltransferase EZH2, inhibiting cellular proliferation and tumor growth in preclinical cancer models and increasing survival rates in clinical settings.

Note: This is the inactive form of the statin. To activate, add one equivalent of sodium hydroxide to convert it to the sodium form.

Product Info

Cas No.

79902-63-9

Purity

≥98%

Formula

C25H38O5

Formula Wt.

418.57

Chemical Name

2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester

IUPAC Name

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3, 7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate

Synonym

Synvinolin, MK-733, Denan, Liponorm, Lodales, Simovil, Sinvacor, Sivastin, Zocor, Zocord

Melting Point

135-138°C

Solubility

Soluble in DMSO (540 mg/mL), ethanol (160 mg/mL), methanol (200 mg/mL). Insoluble in water.

Appearance

Light white crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

S3449 MSDS PDF

Info Sheet

S3449 Info Sheet PDF

Brochure

Statins Flyer

References

Zhou J, Li W, Xie Q, et al. Effects of simvastatin on glucose metabolism in mouse MIN6 cells. J Diabetes Res. 2014;2014:376570. PMID: 24995341.

Banach M, Czuczwar SJ, Borowicz KK. Statins - are they anticonvulsant? Pharmacol Rep. 2014 Aug;66(4):521-8. PMID: 24948050.

Wang Q, Wei X, Gao H, et al. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory. Neuroscience. 2014 May 16;267:57-66. PMID: 24613723.

Yang N, Cui Y, Tan J, et al. Local injection of a single dose of simvastatin augments osteoporotic bone mass in ovariectomized rats. J Bone Miner Metab. 2014 May;32(3):252-60. PMID: 23934055.

Ishikawa S, Hayashi H, Kinoshita K, et al. Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer. Int J Cancer. 2013 Dec 17. [Epub ahead of print]. PMID: 24346863.

Moraes LA, Vaiyapuri S, Sasikumar P, et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood. 2013 Oct 31;122(18):3188-96. PMID: 24030383.

Liu PY, Liu YW, Lin LJ, et al. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009 Jan 6;119(1):131-8. PMID: 19075102.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I527211

    Infigratinib Phosphate

    FGFR inhibitor.

    ≥98%
  • C1633

    Cefotaxime Sodium

    β-lactam cephalosporin; penicillin binding pro...

    ≥96%
  • F1652

    Fenbufen

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • O9458

    Oxolinic Acid

    Fluoroquinolone; bacterial DNA gyrase inhibitor...

    ≥98%
  • P0005

    Pituitary Adenylate Cyclase-activating Polypeptide (1-27), human, sheep, rat

    Endogenous peptide, involved in paracrine and a...

    ≥95%
  • N1610

    Necrostatin-1

    RIP1 inhibitor.

    ≥99%
  • S0225

    SAG Dihydrochloride

    Smoothened agonist.

    ≥98%
  • V0146

    Valsartan

    AT1 inhibitor.

    ≥98%
  • M5746

    Molsidomine

    NO donor; annexin A2 inhibitor.

    ≥98%
  • N3450

    Nimesulide

    NSAID; COX-2 inhibitor.

    ≥98%
  • P8168

    Puromycin Dihydrochloride

    Protein synthesis inhibitor, DPP2 and metallope...

    ≥98%
  • R2812

    Recombinant HIV-1 gp-120

    Recombinant HIV glycoprotein antigen fragment.<...

    ≥95%
  • A5315

    Deoxyandrographolide

    Labdane diterpene found in Andrographolis; cNOS...

    ≥98%
  • Y4802

    YM-201636

    PIKfyve inhibitor.

    ≥98%
  • A016493

    4-Aminopyrimidine

    Building block

    ≥98%
  • N1858

    Neosolaniol

    Type A trichothecene mycotoxin produced by Fusa...

    ≥98%
  • C1624

    Cefuroxime Sodium

    β-lactam; penicillin binding protein inhibitor...

    ≥98%
  • H9661

    Hypocrellin A

    Prevents MHC II antigen presentation.

    ≥77%, contains ~16% B
  • P3456

    Pimobendan

    PDE3 inhibitor.

    ≥99%
  • E7357

    Esomeprazole Potassium

    (S) isomer of omeprazole; H+/K+ ATPase and MAO-...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only